Janney Montgomery Scott LLC Purchases 1,391 Shares of Teleflex Incorporated (NYSE:TFX)

Janney Montgomery Scott LLC boosted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,723 shares of the medical technology company’s stock after buying an additional 1,391 shares during the period. Janney Montgomery Scott LLC’s holdings in Teleflex were worth $2,976,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of TFX. Cromwell Holdings LLC increased its holdings in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after acquiring an additional 49 shares in the last quarter. Avior Wealth Management LLC raised its position in Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Teleflex during the 3rd quarter worth approximately $40,000. True Wealth Design LLC boosted its stake in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Teleflex by 131.1% in the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Truist Financial cut their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Mizuho dropped their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Stock Performance

NYSE TFX opened at $180.23 on Friday. Teleflex Incorporated has a fifty-two week low of $171.69 and a fifty-two week high of $256.85. The stock has a market cap of $8.37 billion, a price-to-earnings ratio of 35.83, a price-to-earnings-growth ratio of 1.78 and a beta of 1.16. The business has a fifty day moving average of $182.11 and a 200-day moving average of $213.29. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period last year, the company earned $3.64 earnings per share. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.